Upload

Loading...

This video is unavailable.

Sorry about that.

Watch Queue

TV Queue

Watch QueueTV Queue

    Loading...

Watch Queue
TV Queue
__count__/__total__
  1. 1

    An Interview with Dan Bell - Clinical Trial Supply Europe

  2. 2

    An Interview with Sue Lee - Clinical Trial Supply Europe

  3. 3

    An Interview with Robert Donnell - Clinical Trial Supply Europe

  4. 4

    Clinical Trial Supply: Top 10 Statistics

  5. 5

    Weird and Wonderful Pharma Facts

  6. 6

    Clinical Trial Supply Europe Video Preview

  7. 7

    The Top 10 Trends that will Shape Pharma

  8. 8

    Welcome message from the Editor - Cold Chain IQ

  9. 9

    Introduction to Pharma IQ

  10. 10

    Interview with Bertan Halil

  11. 11

    Ariette Van Strien Interview - Clinical Trial Supply Europe

  12. 12

    Steve Jacobs Interview - Clinical Trial Supply Europe

  13. 13

    Bill Skinner & Toby Winchester, Pfizer: The Smaller the Better -- Compound Management Goes 'Nano'

  14. 14

    Robert Schmitt, Abbott: Delivering Compounds to Evolving Drug Discovery Departments

  15. 15

    Duncan McHale, AstraZeneca: The Road To Personlised Medicine

  16. 16

    Neal Mullen: Some Secrets to Success of iPad Application in E-Health

  17. 17

    Marc Descamps: The Rise of Academic/Industry Collaboration in Amorphous Material Studies

  18. 18

    Graham White: Flexible Recruitment Approaches to Keep Ahead in the Race for Talent

  19. 19

    Global Pharma Contract Manufacturing for Pharma & Bio: Trailer

  20. 20

    Why should you work with Pharma IQ?

  21. 21

    Fergus Sweeney, EMA: Increasing Inspection Coverage in the Wake of Globalisation

  22. 22

    Dr. Yves Juillet, DIA President - Top 3 Regulations Impacting Pharma in 2011 - 2012

  23. 23

    Valea Video Series - Introduction to Valea

  24. 24

    Valea Video Series - An Overview

  25. 25

    Valea Video Series - Mechanics

  26. 26

    Valea Video Series - Life Sciences & Chemistry

  27. 27

    Valea Video Series - Legal Services

  28. 28

    Dr Ronald Frank, Leibniz, FMP: EU Openscreen

  29. 29

    Tenna Juul Schrøder, Lundbeck: Outsourcing Parts of your Compound Management Strategy

  30. 30

    Oliver Peter PhD, Actelion: Compounds, Biosamples and Materials Management

  31. 31

    Jose A. Quiroz, Dart Neuroscience: Compound Informatics and research Information

  32. 32

    Andrew Owen, MRC: Developments in Pharmacogenetics & Drug Transporters

  33. 33

    Chris Brogan: Which Social Networks Should You Use?

  34. 34

    Chris Brogan: What is PharmaWall?

  35. 35

    Chris Brogan: Make Your Patient the Hero

  36. 36

    Chris Brogan: Listening To Patients with Social Media

  37. 37

    Chris Brogan: Connections, Referrals, Awareness, Presence in Social Media in Pharma

  38. 38

    David Elder, GSK: Drug Discovery [Part 4] The Rise of Amorphous

  39. 39

    David Elder, GSK: Drug Discovery [Part 2] Critical thoughts on Stability

  40. 40

    David Elder, GSK: Drug Discovery [Part 5] Considering Genotoxic and Carcinogenic Impurities

  41. 41

    David Elder, GSK: Drug Discovery [Part 3] The Focus on Solubility

  42. 42

    David Elder, GSK: Drug Discovery [Part 1] An Overview of Externalisation in the Pharma Industry

Loading...
Working...
to add this to Watch Later

Add to